UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~December~~March 31, ~~2021~~2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 1-4383

ESPEY MFG. & ELECTRONICS CORP.

(Exact name of registrant as specified in its charter)

NEW YORK	Trading Symbol	14-1387171
(State of incorporation)	ESP	(I.R.S. Employer's Identification No.)

233 Ballston Avenue, Saratoga Springs, New York 12866

(Address of principal executive offices)

518-245-4400

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company:

	☐ Large accelerated filer	☐ Non-accelerated filer
	☐ Accelerated filer	☒ Smaller reporting company
		☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes ☒ No

At ~~February 11,~~May 12, 2022, there were 2,702,633 shares outstanding of the registrant's Common stock, $.33-1/3 par value.

ESPEY MFG. & ELECTRONICS CORP.

Quarterly Report on Form 10-Q

I N D E X


PART I	FINANCIAL INFORMATION		PAGE

	Item 1	Financial Statements:

		Balance Sheets - ~~December~~March 31, ~~2021~~2022 (Unaudited) and June 30, 2021	1

		Statements of Comprehensive Income (Loss) (Unaudited) - Three and ~~Six~~Nine Months Ended ~~December~~March 31, ~~2021~~ 2022 and ~~2020~~2021	2

		Statements of Changes in Stockholders’ Equity (Unaudited) – Three and ~~Six~~Nine Months Ended ~~December~~March 31, ~~2021~~ 2022 and ~~2020~~2021	3

		Statements of Cash Flows (Unaudited) - ~~Six~~Nine Months Ended ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021	7

		Notes to Financial Statements (Unaudited)	8

Index

PART I: FINANCIAL INFORMATION

ESPEY MFG. & ELECTRONICS CORP.

Balance Sheets

~~December~~March 31, ~~2021~~2022 (Unaudited) and June 30, 2021

	December 31, 2021			June 30, 2021			March 31, 2022			June 30, 2021
ASSETS
Cash and cash equivalents	$	7,018,282		$	6,802,712		$	7,282,832		$	6,802,712
Investment securities		3,057,000			3,092,000			3,209,297			3,092,000
Trade accounts receivable, net of allowance of $3,000		4,888,399			5,353,781			5,642,869			5,353,781
Income tax receivable		252,643			249,602			91,163			249,602

Inventories:
Raw materials		2,074,883			2,111,058			2,142,025			2,111,058
Work-in-process		242,094			326,198			259,932			326,198
Costs related to contracts in process		17,012,234			16,354,636			16,542,146			16,354,636
Total inventories		19,329,211			18,791,892			18,944,103			18,791,892

Prepaid expenses and other current assets		808,857			700,297			928,836			700,297
Total current assets		35,354,392			34,990,284			36,099,100			34,990,284

Property, plant and equipment, net		2,833,961			2,990,519			2,833,188			2,990,519

Total assets	$	38,188,353		$	37,980,803		$	38,932,288		$	37,980,803

LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	$	2,585,174		$	2,718,173		$	2,098,248		$	2,718,173
Accrued expenses:
Salaries and wages		649,089			475,667			577,154			475,667
Vacation		656,292			672,611			752,457			672,611
ESOP payable		168,318			0—			245,362			0—
Other		57,037			126,014			271,803			126,014
Payroll and other taxes withheld		278,924			409,881			58,957			409,881
Contract liabilities		2,904,746			3,077,605			3,354,066			3,077,605
Total current liabilities		7,299,580			7,479,951			7,358,047			7,479,951

Deferred tax liabilities		134,649			168,557			118,221			168,557
Total liabilities		7,434,229			7,648,508			7,476,268			7,648,508

Commitments and contingencies (See Note 5)

Common stock, par value $.33-1/3 per share
Authorized 10,000,000 shares; Issued 3,129,874 shares as of December 31, 2021 and June 30, 2021. Outstanding 2,702,633 shares as of December 31, 2021 and June 30, 2021 (includes 267,861 and 279,429 Unearned ESOP shares, respectively)		1,043,291			1,043,291
Authorized 10,000,000 shares; Issued 3,129,874 shares as of March 31, 2022 and June 30, 2021. Outstanding 2,702,633 shares as of March 31, 2022 and June 30, 2021 (includes 262,077 and 279,429 Unearned ESOP shares, respectively)								1,043,291			1,043,291
Capital in excess of par value		23,120,663			23,026,096			23,160,362			23,026,096
Accumulated other comprehensive loss		(2,361	)		(2,361	)		(1,523	)		(2,361	)
Retained earnings		17,741,992			17,414,730			18,403,351			17,414,730
		41,903,585			41,481,756			42,605,481			41,481,756

Less: Unearned ESOP shares		(5,110,770	)		(5,110,770	)		(5,110,770	)		(5,110,770	)
Cost of 427,241 shares of common stock in treasury as of December 31, 2021 and June 30, 2021		(6,038,691	)		(6,038,691	)
Cost of 427,241 shares of common stock in treasury as of March 31, 2022 and June 30, 2021								(6,038,691	)		(6,038,691	)
Total stockholders’ equity		30,754,124			30,332,295			31,456,020			30,332,295

Total liabilities and stockholders' equity	$	38,188,353		$	37,980,803		$	38,932,288		$	37,980,803

Three and ~~Six~~Nine Months Ended ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021

	Three Months Ended December 31,					Six Months Ended December 31,					Three Months Ended March 31,					Nine Months Ended March 31,
	2021		2020			2021		2020			2022		2021			2022		2021

Net sales	$	7,458,050	$	6,962,065		$	15,003,482	$	14,227,580		$	8,620,049	$	4,205,068		$	23,623,531	$	18,432,648
Cost of sales		6,251,233		6,248,604			12,443,567		12,386,745			6,885,169		4,392,222			19,328,736		16,778,967
Gross profit		1,206,817		713,461			2,559,915		1,840,835
Gross profit (loss)												1,734,880		(187,154	)		4,294,795		1,653,681

Selling, general and administrative expenses		1,186,168		945,478			2,180,990		1,860,104			933,725		990,311			3,114,715		2,850,415
Operating income (loss)		20,649		(232,017	)		378,925		(19,269	)		801,155		(1,177,465	)		1,180,080		(1,196,734	)

Other income
Interest income		1,716		1,753			3,312		16,970			2,987		2,486			6,299		19,456
Other		10,105		13,734			28,076		16,861			2,674		4,589			30,750		21,450
Total other income		11,821		15,487			31,388		33,831			5,661		7,075			37,049		40,906

Income (loss) before provision (benefit) for income taxes		32,470		(216,530	)		410,313		14,562			806,816		(1,170,390	)		1,217,129		(1,155,828	)

Provision (benefit) for income taxes		11,269		(35,524	)		83,051		5,745			145,457		(100,276	)		228,508		(94,531	)

Net income (loss)	$	21,201	$	(181,006	)	$	327,262	$	8,817		$	661,359	$	(1,070,114	)	$	988,621	$	(1,061,297	)

Other comprehensive income, net of tax:
Unrealized gain on investment securities		0—		2,712			0—		1,038
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on investment securities												838		(167	)		838		871

Total comprehensive income (loss)	$	21,201	$	(178,294	)	$	327,262	$	9,855		$	662,197	$	(1,070,281	)	$	989,459	$	(1,060,426	)

Net income (loss) per share:
Basic	$	0.01	$	(0.08	)	$	0.14	$	0.00		$	0.27	$	(0.44	)	$	0.41	$	(0.44	)
Diluted	$	0.01	$	(0.08	)	$	0.14	$	0.00		$	0.27	$	(0.44	)	$	0.41	$	(0.44	)

Weighted average number of shares outstanding:
Basic		2,429,051		2,402,665			2,426,159		2,402,649			2,434,836		2,405,670			2,429,009		2,403,641
Diluted		2,429,199		2,402,665			2,426,233		2,404,043			2,434,836		2,405,670			2,429,059		2,403,641

Dividends per share:	$	0—	$	0.25		$	0—	$	0.50		$	0.00	$	0.00		$	0.00	$	0.50

							Accumulated																						Accumulated
					Capital in		Other										Unearned			Total							Capital in		Other										Unearned			Total
	Outstanding		Common		Excess of		Comprehensive			Retained		Treasury		Treasury			ESOP			Stockholders’			Outstanding		Common		Excess of		Comprehensive			Retained		Treasury		Treasury			ESOP			Stockholders’
	Shares		Amount		Par Value		Loss			Earnings		Shares		Amount			Shares			Equity			Shares		Amount		Par Value		(Loss) Income			Earnings		Shares		Amount			Shares			Equity
Balance as of September 30, 2021		2,702,633	$	1,043,291	$	23,078,872	$	(2,361	)	$	17,720,791		427,241	$	(6,038,691	)	$	(5,110,770	)	$	30,691,132
Balance as of December 31, 2021																						Balance as of December 31, 2021		2,702,633	$	1,043,291	$	23,120,663	$	(2,361	)	$	17,741,992		427,241	$	(6,038,691	)	$	(5,110,770	)	$	30,754,124

Comprehensive income:																						Comprehensive income:

Net income											21,201										21,201	Net income											661,359										661,359

Other comprehensive income, net of tax of $176																						Other comprehensive income, net of tax of $176								838													838

Total comprehensive income																						Total comprehensive income																					662,197

Stock-based compensation						41,791															41,791	Stock-based compensation						39,699															39,699

Balance as of December 31, 2021		2,702,633	$	1,043,291	$	23,120,663	$	(2,361	)	$	17,741,992		427,241	$	(6,038,691	)	$	(5,110,770	)	$	30,754,124
Balance as of March 31, 2022																						Balance as of March 31, 2022		2,702,633	$	1,043,291	$	23,160,362	$	(1,523	)	$	18,403,351		427,241	$	(6,038,691	)	$	(5,110,770	)	$	31,456,020

							Accumulated																						Accumulated
					Capital in		Other										Unearned			Total							Capital in		Other										Unearned			Total
	Outstanding		Common		Excess of		Comprehensive			Retained		Treasury		Treasury			ESOP			Stockholders’			Outstanding		Common		Excess of		Comprehensive			Retained		Treasury		Treasury			ESOP			Stockholders’
	Shares		Amount		Par Value		Loss			Earnings		Shares		Amount			Shares			Equity			Shares		Amount		Par Value		(Loss) Income			Earnings		Shares		Amount			Shares			Equity
Balance as of June 30, 2021		2,702,633	$	1,043,291	$	23,026,096	$	(2,361	)	$	17,414,730		427,241	$	(6,038,691	)	$	(5,110,770	)	$	30,332,295	Balance as of June 30, 2021		2,702,633	$	1,043,291	$	23,026,096	$	(2,361	)	$	17,414,730		427,241	$	(6,038,691	)	$	(5,110,770	)	$	30,332,295

Comprehensive income:

Net income											327,262										327,262	Net income											988,621										988,621

Other comprehensive income, net of tax of $176																						Other comprehensive income, net of tax of $176								838													838

Total comprehensive income																						Total comprehensive income																					989,459

Stock-based compensation						94,567															94,567	Stock-based compensation						134,266															134,266

Balance as of December 31, 2021		2,702,633	$	1,043,291	$	23,120,663	$	(2,361	)	$	17,741,992		427,241	$	(6,038,691	)	$	(5,110,770	)	$	30,754,124
Balance as of March 31, 2022																						Balance as of March 31, 2022		2,702,633	$	1,043,291	$	23,160,362	$	(1,523	)	$	18,403,351		427,241	$	(6,038,691	)	$	(5,110,770	)	$	31,456,020

							Accumulated																								Accumulated
					Capital in		Other												Unearned			Total							Capital in		Other											Unearned			Total
	Outstanding		Common		Excess of		Comprehensive			Retained			Treasury			Treasury			ESOP			Stockholders’			Outstanding		Common		Excess of		Comprehensive			Retained			Treasury		Treasury			ESOP			Stockholders’
	Shares		Amount		Par Value		(Loss) Income			Earnings			Shares			Amount			Shares			Equity			Shares		Amount		Par Value		Loss			Earnings			Shares		Amount			Shares			Equity
Balance as of September 30, 2020		2,402,633	$	1,009,958	$	19,120,380	$	(4,781	)	$	18,386,755			627,241		$	(7,650,805	)	$	0—		$	30,861,507
Balance as of December 31, 2020																										2,702,633	$	1,043,291	$	22,995,640	$	(2,069	)	$	17,605,090			427,241	$	(6,038,691	)	$	(5,487,000	)	$	30,116,261

Comprehensive loss:

Net loss											(181,006	)											(181,006	)											(1,070,114	)										(1,070,114	)

Other comprehensive income, net of tax of $721								2,712															2,712
Other comprehensive loss, net of tax of $ (44)																																(167	)													(167	)

Total comprehensive loss																							(178,294	)																						(1,070,281	)

Stock-based compensation						33,707																	33,707							25,412																25,412

Dividends paid on common stock $0.25 per share											(600,659	)											(600,659	)

Sale of stock to ESOP		300,000		33,333		3,841,553								(200,000	)		1,612,114			(5,487,000	)		—

Balance as of December 31, 2020		2,702,633	$	1,043,291	$	22,995,640	$	(2,069	)	$	17,605,090			427,241		$	(6,038,691	)	$	(5,487,000	)	$	30,116,261
Balance as of March 31, 2021																										2,702,633	$	1,043,291	$	23,021,052	$	(2,236	)	$	16,534,976			427,241	$	(6,038,691	)	$	(5,487,000	)	$	29,071,392

Accumulated

Capital in

Other

Unearned

Total
Outstanding

Common

Excess of

Comprehensive

Retained

Treasury
Treasury

ESOP

Stockholders’
Shares

Amount

Par Value

(Loss) Income

Earnings

Shares

Amount

Shares

Equity
Balance as of June 30, 2020
2,402,633
$
1,009,958
$
19,073,213
$
(3,107
)
$
18,797,589
627,241
$
(7,650,805
)
$
0—
$
31,226,848

Comprehensive income:
Net income
8,817
8,817

Other comprehensive income, net of tax of $276
1,038
1,038

Total comprehensive income
9,855

Stock-based compensation
80,874
80,874

Dividends paid on common stock
$0.50 per share
(1,201,316
)
(1,201,316
)

Sale of stock to ESOP
300,000
33,333
3,841,553
(200,000
)
1,612,114
(5,487,000
)
—

Balance as of December 31, 2020
2,702,633
$
1,043,291
$
22,995,640
$
(2,069
)
$
17,605,090
427,241
$
(6,038,691
)
$
(5,487,000
)
$
30,116,261

							Accumulated
					Capital in		Other												Unearned			Total
	Outstanding		Common		Excess of		Comprehensive			Retained			Treasury			Treasury			ESOP			Stockholders’
	Shares		Amount		Par Value		(Loss) Income			Earnings			Shares			Amount			Shares			Equity
Balance as of June 30, 2020		2,402,633	$	1,009,958	$	19,073,213	$	(3,107	)	$	18,797,589			627,241		$	(7,650,805	)	$	0—		$	31,226,848

Comprehensive loss:

Net loss											(1,061,297	)											(1,061,297	)

Other comprehensive income, net of tax of $ 232								871															871

Total comprehensive loss																							(1,060,426	)

Stock-based compensation						106,286																	106,286

Dividends paid on common stock $0.50 per share											(1,201,316	)											(1,201,316	)

Sales of stock to ESOP		300,000		33,333		3,841,553								(200,000	)		1,612,114			(5,487,000	)		0—

Balance as of March 31, 2021		2,702,633	$	1,043,291	$	23,021,052	$	(2,236	)	$	16,534,976			427,241		$	(6,038,691	)	$	(5,487,000	)	$	29,071,392

	December 31, 2021			December 31, 2020			March 31, 2022			March 31, 2021
Cash Flows from Operating Activities:
Net income	$	327,262		$	8,817
Net income (loss)							$	988,621		$	(1,061,297	)

Adjustments to reconcile net income to net cash provided by operating activities:
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation		94,567			80,874			134,266			106,286
Depreciation		253,846			271,341			373,830			399,197
ESOP compensation expense		168,318			56,274			245,362			218,750
Gain on disposal of assets								(2,000	)		0—
Deferred income tax benefit		(33,908	)		(35,524	)		(50,336	)		(53,873	)
Changes in assets and liabilities:
Decrease in trade accounts receivable		465,382			4,805,803
Increase in income taxes receivable		(3,041	)		(86,274	)
Increase in ESOP receivable due to dividends on unallocated shares		0—			(18,726	)
(Increase) decrease in trade accounts receivable								(289,088	)		6,755,964
Decrease (increase) in income taxes receivable								158,439			(168,201	)
Increase in inventories		(537,319	)		(1,706,735	)		(152,211	)		(4,474,719	)
Increase in prepaid expenses and other current assets		(108,560	)		(109,615	)		(228,539	)		(55,565	)
(Decrease) increase in accounts payable		(132,999	)		392,287
Decrease in accounts payable								(619,925	)		(1,531	)
Increase (decrease) in accrued salaries and wages		173,422			(125,060	)		101,487			(117,859	)
Decrease in vacation accrual		(16,319	)		(23,674	)
Increase in vacation accrual								79,846			83,430
Decrease in ESOP Payable		0—			(56,274	)		0—			(75,000	)
Decrease in other accrued expenses		(68,977	)		(228,136	)
Increase (decrease) in other accrued expenses								145,789			(160,678	)
(Decrease) increase in payroll and other taxes withheld		(130,957	)		276,315			(350,924	)		278,375
Decrease in contract liabilities		(172,859	)		(524,947	)
Increase in contract liabilities								276,461			562,728
Decrease in income taxes payable		0—			(47,707	)		0—			(47,707	)
Net cash provided by operating activities		277,858			2,929,039			811,078			2,188,300

Cash Flows from Investing Activities:
Additions to property, plant and equipment		(97,288	)		(29,173	)		(216,500	)		(34,337	)
Proceeds from sale of fixed assets								2,000			0—
Purchase of investment securities		(2,061,000	)		(2,391,686	)		(3,692,458	)		(4,294,897	)
Proceeds from sale/maturity of investment securities		2,096,000			4,331,407			3,576,000			6,429,064
Net cash (used in) provided by investing activities		(62,288	)		1,910,548			(330,958	)		2,099,830

Cash Flows from Financing Activities:
Dividends on common stock		0—			(1,201,316	)		0—			(1,201,316	)
Net cash used in financing activities		0—			(1,201,316	)		0—			(1,201,316	)

Increase in cash and cash equivalents		215,570			3,638,271			480,120			3,086,814
Cash and cash equivalents, beginning of period		6,802,712			5,402,122			6,802,712			5,402,122
Cash and cash equivalents, end of period	$	7,018,282		$	9,040,393		$	7,282,832		$	8,488,936

Supplemental Schedule of Cash Flow Information:
Income taxes paid	$	120,000		$	175,250		$	120,000		$	175,250

In the opinion of management the accompanying unaudited financial statements contain all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the results for such periods. The results for any interim period are not necessarily indicative of the results to be expected for the full fiscal year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, inventories, income taxes, and stock-based compensation. Specific to inventories, including work-in-process and contracts in process, management evaluates, quarterly, those estimates used in determining the cost to complete for each contract on Espey Mfg. & Electronics Corp. (the “Company”) sales backlog. The change in estimates may affect the reported amount of inventories and gross profit in the current or a future period. Management bases its estimates on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. These financial statements should be read in conjunction with the Company's most recent audited financial statements included in its report on Form 10-K for the year ended June 30, 2021. Certain reclassifications may have been made to the prior year financial statements to conform to the current year presentation.

Accounting Standards Codification (“ASC”) 820 establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

The carrying amounts of financial instruments, including cash and cash equivalents, short term investments, accounts receivable, accounts payable and accrued expenses, approximated fair value as of ~~December~~March 31, ~~2021~~2022 and June 30, 2021 because of the immediate or short-term maturity of these financial instruments.

Investment securities at ~~December~~March 31, ~~2021 and June 30, 2021 consist~~2022 consists of certificates of deposit ~~which are classified~~and municipal bonds and at June 30, 2021 consisted of certificates of deposit. The Company classifies investment securities as available-for-sale ~~securities and~~which have been determined to be level 1 assets. The cost, gross unrealized gains, gross unrealized losses and fair value of available-for-sale securities by major security type at ~~December~~March 31, ~~2021~~2022 and June 30, 2021 are as follows:

The portfolio is diversified and highly liquid and primarily consists of investment grade fixed income instruments. At ~~December~~March 31, ~~2021,~~2022, the Company did not have any investments in individual securities that have been in a continuous loss position considered to be other than temporary.

As of ~~December~~March 31, ~~2021~~2022 and June 30, 2021, the remaining contractual maturities of available-for-sale securities were as follows:

Basic net income (loss) per share excludes dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income of the Company. The computation of diluted net income per share, excluded options to purchase ~~316,912~~264,978 shares of our common stock for the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 and the computation of diluted net ~~(loss) income~~loss per share, excluded options to purchase ~~315,337 and 253,312~~312,187 shares for the three and ~~six~~nine months ended ~~December~~March 31, ~~2020,~~2021, as the effect of including them would be anti-dilutive. As unearned shares owned by the Company’s sponsored leveraged employee stock ownership plan (the “ESOP”) are released or committed-to-be-released, the shares become outstanding for earnings-per-share computations.

The Company follows ASC 718 in establishing standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services, as well as transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions with employees, except for equity instruments held by employee share ownership plans.

Total stock-based compensation expense recognized in the statements of comprehensive income (loss) for the three-month periods ended ~~December~~March 31, 2022 and 2021 was $39,699 and ~~2020 was $41,791 and $33,707,~~$25,412, respectively, before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSO”) for the three-month periods ended ~~December~~March 31, 2022 and 2021, was $6,582 and ~~2020, was $8,757 and $5,143,~~$7,366, respectively. The deferred tax benefit related to the NQSO’s as of ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021 was approximately ~~$1,839~~$1,382 and ~~$1,080,~~$1,547, respectively. Total stock-based compensation expense recognized in the statements of comprehensive income (loss) for the ~~six-month~~nine-month periods ended ~~December~~March 31, 2022 and 2021, was $134,266 and ~~2020, was $94,567 and $80,874,~~$106,286, respectively, before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSO”) for the ~~six-month~~nine-month periods ended ~~December~~March 31, 2022 and 2021, was $22,705 and ~~2020, was $16,123 and $18,131,~~$25,497, respectively. The deferred tax benefit related to the NQSO’s as of ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021 was approximately ~~$3,386~~$4,768 and ~~$3,808,~~$5,354, respectively. The remaining stock option expense in each year related to incentive stock options (“ISO”) which are not deductible by the corporation when exercised, assuming a qualifying disposition and as such no deferred tax benefit was established related to these amounts.

As of ~~December~~March 31, ~~2021,~~2022, there was approximately ~~$219,311~~$179,612 of unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 21.75 years, of which ~~$179,408~~$146,291 relates to ISO’s and ~~$39,903~~$33,321 relates to NQSO’s. The total deferred tax benefit related to these non-qualified stock option awards is expected to be ~~$8,380.~~$6,997.

The Company has one employee stock option plan under which options or stock awards may be granted, the 2017 Stock Option and Restricted Stock Plan (the "2017 Plan"). The Board of Directors may grant options to acquire shares of common stock to employees and non-employee directors of the Company at the fair market value of the common stock on the date of grant. The maximum aggregate number of shares of Common Stock subject to options or awards to non-employee directors is 133,000 and the maximum aggregate number of shares of Common Stock subject to options or awards granted to non-employee directors during any single fiscal year is the lesser of 13,300 and 33 1/3% of the total number of shares subject to options or awards granted in such fiscal year. The maximum number of shares subject to options or awards granted to any individual employee may not exceed 15,000 in a fiscal year. Generally, options granted have a two-year vesting period based on two years of continuous service and have a ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. The plan allows for cancelled or expired options to be re-granted to participants at a later date. Shares issued upon the exercise of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2017 Plan. As of ~~December~~March 31, ~~2021,~~2022, options covering 303,904 shares have been granted, of which ~~228,062~~198,578 are outstanding, and ~~171,938~~201,422 remain available for ~~grant.~~grant, after factoring cancelled or expired options which are eligible to be re-granted. While no further grants of options may be made under the Company’s 2007 Stock Option and Restricted Stock Plan, as of ~~December~~March 31, ~~2021, 98,050~~2022, 66,400 options were outstanding under such plan of which all are vested and exercisable.

ASC 718 requires the use of a valuation model to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates various assumptions including those for dividend yield, volatility, expected life and interest rates.

The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 and ~~2020.~~2021.

Effective March 9, 2021, the Company suspended the payment of its regular quarterly dividend. For the ~~six~~nine months ended ~~December~~March 31, ~~2020,~~2022, the Company ~~declared and~~paid no cash dividends. For the nine months ended March 31, 2021, the Company paid regular cash dividends of $0.50 per ~~share, and for the six months ended December 31, 2021 the Company paid no cash dividends.~~share. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options. The expected option term (in years) represents the estimated period of time until exercise and is based on actual historical experience.

The following table summarizes stock option activity during the ~~six~~nine months ended ~~December~~March 31, ~~2021:~~2022:

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported on the NYSE American on ~~December~~March 31, ~~2021~~2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders had exercised their options on ~~December~~March 31, ~~2021.~~2022. This amount changes based on the fair market value of the Company’s common stock. The intrinsic value of options exercised during the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021 was $0, resulting from no option exercise activity during those periods.

The following table summarizes changes in non-vested stock options during the ~~six~~nine months ended ~~December~~March 31, ~~2021:~~2022:

The Company from time to time, enters into standby letters of credit agreements with financial institutions primarily relating to the guarantee of future performance on certain contracts. Contingent liabilities on outstanding standby letters of credit agreements aggregated to 0 at ~~December~~March 31, ~~2021~~2022 and June 30, 2021. The Company, as a U.S. Government contractor, is subject to audits, reviews, and investigations by the U.S. Government related to its negotiation and performance of government contracts and its accounting for such contracts. Failure to comply with applicable U.S. Government standards by a contractor may result in suspension from eligibility for award of any new government contract and a guilty plea or conviction may result in debarment from eligibility for awards. The government may, in certain cases, also terminate existing contracts, recover damages, and impose other sanctions and penalties. As a result of contract audits the Company will determine a range of possible outcomes and in accordance with ASC 450 “Contingencies” the Company will accrue amounts within a range that appears to be its best estimate of a possible outcome. Adjustments are made to accruals, if any, periodically based on current information.

We are party to various litigation matters and claims arising from time to time in the ordinary course of business. ~~While the results of~~There are no such pending matters ~~cannot be predicted with certainty,~~which we believe ~~that the final outcome of such matters~~ will ~~not~~ have a material adverse effect on our business, financial condition, results of operations or cash flows. ~~Currently, there are no matters pending.~~

The Company follows ASC 606 “Revenue from Contracts with Customers” to determine the recognition of revenue. This standard requires entities to assess the products or services promised in contracts with customers at contract inception to determine the appropriate unit at which to record revenues. Revenue is recognized when control of the promised products or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those products or services.

Significant judgment is required in determining the satisfaction of performance obligations. Revenues from our performance obligations are satisfied over time using the output method which considers the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point. Revenue is recognized when, or as, the customer takes control of the product or services. The output method best depicts the transfer of control to the customer as the output method represents work completed. Control is typically transferred to the customer at the shipping point as the Company has a present right to payment, the customer has legal title to the asset, the customer has the significant risks and rewards of ownership of the asset, and in most instances the customer has accepted the asset.

Total revenue recognized for the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 based on units delivered was ~~$6,100,228~~$7,291,109 and ~~$12,592,464,~~$19,883,573, respectively, compared to ~~$5,865,878~~$3,754,628 and ~~$11,724,584~~$15,479,212 for the same periods in fiscal year 2021. Total revenue recognized for the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 based on milestones achieved was ~~$1,357,822~~$1,328,940 and ~~$2,411,018,~~$3,739,958, respectively, compared to ~~$1,096,187~~$450,440 and ~~$2,502,996~~$2,953,436 for the same periods in fiscal year 2021.

The Company offers a standard one-year product warranty. Product warranties offered by the Company are classified as assurance-type warranties, which means, the warranty only guarantees that the good or service functions as promised. Based on this, the provided warranty is not considered to be a distinct performance obligation. The impact of variable consideration has been considered but none identified which would be required to be allocated to the transaction price as of ~~December~~March 31, ~~2021.~~2022. Our payment terms are generally 30-60 days.

Contract liabilities were ~~$2,904,746~~$3,354,066 and $3,077,605 as of ~~December~~March 31, ~~2021~~2022 and June 30, 2021, respectively. The ~~decrease~~increase in contract liabilities is primarily due to ~~revenue recognized, offset in part by,~~ the advance collection of cash on specific ~~contracts.~~contracts, offset in part, by revenue recognized. Revenue recognized, that was in contract liabilities in the beginning of the fiscal year, approximated $811,000 for the nine months ended March 31, 2022. The Company used the practical expedient to expense incremental costs incurred to obtain a contract when the contract term is less than one year.

The Company’s backlog at ~~December~~March 31, ~~2021~~2022 totaling approximately ~~$70.1~~$76.2 million is projected, based on expected due dates, to be recognized in the following fiscal years: ~~30%~~13% in 2022; ~~43%~~48% in 2023; ~~21%~~29% in 2024, and 6%10% thereafter.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” ASU 2019-12 amends ASC 740 to simplify the accounting for income taxes by removing certain exceptions for investments, intraperiod allocations and interim calculations, and adding guidance to reduce complexity in the accounting standard under the FASB’s simplification initiative. ASU 2019-12 is effective for public entities for fiscal years beginning after December 15, 2020. Upon adoption, the amendments in ASU 2019-12 should be applied on a prospective basis to all periods presented. The Company adopted the new guidance under ASU 2019-12 in the first quarter of fiscal year 2021 and removed the exception for intraperiod allocations from its interim period tax provision calculation, accordingly. The removal of the exception for intraperiod allocations did not have a material impact on the Company.

The Company sponsors a leveraged employee stock ownership plan (the “ESOP”) that covers all nonunion employees who work 1,000 or more hours per year and are employed on June 30. Prior to December 1, 2020, the ESOP owned 469,119 shares, all of which were allocated to employees. On December 1, 2020, pursuant to a Stock Purchase Agreement dated as of such date, the Company, by selling 300,000 shares of its common stock, par value $0.33 1/3 per share, to the Espey Mfg. & Electronics Corp. Employee Stock Ownership Plan Trust, provided more shares to be allocated to employees for services rendered over the next 15 years. The ESOP paid $18.29 per share, for an aggregate purchase price of $5,487,000. The determination of the purchase price was based on a fairness opinion obtained by an independent valuation firm. The ESOP borrowed from the Corporation an amount equal to the purchase price. The loan will be repaid in fifteen (15) equal annual installments of principal. The Board of Directors has fixed the interest rate and the unpaid balance will bear interest at a fixed rate of 3.00% per annum.

The Board of Directors of the Company had approved a purchase price per share equal to the lesser of the trading value on the day of closing or the lowest price listed in the valuation established by the independent valuation firm plus $0.25. The valuation identified a range of $18.04 - $19.43 per share.

In making the sale, the Company relied on the exemption from registration under Section 4(2) of the Securities Act of 1933, as amended, because the shares sold were offered only to the ESOP.

After giving effect to the transaction, the ESOP owned 769,119 shares of the Company's 2,702,633 outstanding shares of common stock as of December 1, 2020.

The Company makes annual contributions to the ESOP equal to the ESOP's debt service less dividends on unallocated shares received by the ESOP. Any dividends on unallocated shares received by the ESOP are used to pay debt service. Any dividends on allocated ESOP shares are recorded as a reduction of retained earnings. As the debt is repaid, shares are released and allocated to active employees, based on the proportion of debt service paid in the year. The Company accounts for its ESOP in accordance with FASB ASC 718-40. Accordingly, the shares purchased by the ESOP are reported as Unearned ESOP shares in the balance sheets and the statements of changes in ~~stockholders’~~stockholders' equity. As shares are released or committed-to-be-released, the Company reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings-per-share (EPS) computations. ESOP compensation expense was ~~$83,812~~$77,045 and ~~$56,274~~$162,476 for the three-month periods ended ~~December~~March 31, ~~2021~~2022 and ~~2020,~~2021, respectively. ESOP compensation expense was ~~$168,318~~$245,362 and ~~$56,274~~$218,750 for the ~~six-month~~nine-month periods ended ~~December~~March 31, ~~2021~~2022 and ~~2020,~~2021, respectively.

The ESOP shares as of ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021 were as follows:

The Company may at times be required to repurchase shares at the ESOP participants’ request at the shares’ fair market value. During the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 and ~~2020,~~2021, the Company did not repurchase shares previously held by the ESOP.

The ESOP allows for eligible participants to take whole share distributions from the Plan on specific dates in accordance with the provision of the Plan. Share distributions from the ESOP during the ~~six~~nine months ended ~~December~~March 31, 2022 and 2021 totaled 14,265 and ~~2020 totaled 8,285 and 456~~2,015 shares, respectively.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Espey Mfg. & Electronics Corp. (“Espey”) is a power electronics design and original equipment manufacturing (OEM) company with a long history of developing and delivering highly reliable products for use in military and severe environment applications. Design, manufacturing, and testing is performed in our 150,000+ square foot facility located at 233 Ballston Ave, Saratoga Springs, New York. Espey is classified as a “smaller reporting company” for purposes of the reporting requirements under the Securities Exchange Act of 1934, as amended. Espey’s common stock is publicly-traded on the NYSE American under the symbol “ESP.”

Espey began operations after incorporation in New York in 1928. We strive to remain competitive as a leader in high power energy conversion and transformer solutions through the design and manufacture of new and improved products by using advanced and “cutting edge” electronics technologies.

Espey is ISO 9001:2015 and AS9100:2016 certified. Our primary products are power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, antennas and high power radar systems. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Espey services include design and development to specification, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment. Espey is vertically integrated, meaning that the Company produces individual components (including inductors), populates printed circuit boards, fabricates metalwork, paints, wires, qualifies, and fully tests items, mechanically, electrically and environmentally, in house. Portions of the manufacturing and testing process are subcontracted to vendors from time to time.

The Company markets its products primarily through its own direct sales organization and through outside sales representatives. Business is solicited from large industrial manufacturers and defense companies, the government of the United States, foreign governments and major foreign electronic equipment companies. Espey is also on the eligible list of contractors with the United States Department of Defense. We pursue opportunities for prime contracts directly with the Department of Defense and are generally automatically solicited by Department of Defense procurement agencies for their needs falling within the major classes of products produced by the Company. Espey contracts with the Federal Government under cage code 20950 as Espey Mfg. & Electronics Corp.

There is competition in all classes of products manufactured by the Company, ranging from divisions of the largest electronic companies, to many small companies. The Company's sales do not represent a significant share of the industry's market for any class of its products. The principal methods of competition for electronic products of both a military and industrial nature include, among other factors, price, product performance, the experience of the particular company and history of its dealings in such products.

Our business is not seasonal. However, the concentration of our business in the rail industry, and in equipment for military applications and industrial applications, and our customer concentrations expose us to on-going associated risks. These risks include, without limitation, fluctuating requirements for power supplies in the rail industry, dependence on appropriations from the United States Government and the governments of foreign nations, program allocations, the potential of governmental termination of orders for convenience, and the general strength of the industry sectors in which our customers transact business.

Future procurement needs supporting the military and the rail industry continue to drive competition. Many of our competitors have invested, and they continue to invest aggressively in upfront product design costs and accept lower profit margins as a strategic means of maintaining existing business and enhancing market share. This continues to put pressure on the pricing of our current products and has lowered our profit margins on some of our new business. In order to compete effectively for new business, in some cases we have invested in upfront design costs, thereby reducing initial profitability as a means of procuring new long-term programs. As part of our strategy, we adjust our pricing in order to achieve a balance which enables us both to retain repeat programs while being more competitive in bidding on new programs.

We continue to place an emphasis on securing “build to print” opportunities, which will allow production work to go directly to the manufacturing floor, limiting the impact on our engineering staff. This allows us to keep our manufacturing team busy while the products are being developed in-house to production.

The total backlog at ~~December~~March 31, ~~2021~~2022 was approximately ~~$70.1~~$76.2 million, which included ~~$45.8~~$47.5 million from four significant customers, compared to approximately ~~$60.1~~$67.3 million at ~~December~~March 31, ~~2020,~~2021, which included ~~$26.5~~$43.6 million from ~~three~~five significant customers. The Company’s total backlog represents the estimated remaining sales value of work to be performed under firm contracts. The funded portion of this backlog at ~~December~~March 31, ~~2021~~2022 is approximately ~~$69.7~~$75.8 million. This includes items that have been authorized and appropriated by Congress and/or funded by the customer. The unfunded backlog at ~~December~~March 31, ~~2021~~2022 is approximately $0.4 million and represents two firm multi-year orders from a single customer for which funding has not yet been appropriated by Congress or funded by our customer. While there is no guarantee that future budgets and appropriations will provide funding for individual programs, management has included in unfunded backlog only those programs that it believes are likely to receive funding based on discussions with customers and program status. The unfunded backlog at ~~December~~March 31, ~~2020~~2021 was approximately ~~$2.4~~$2.1 million, comprised of the same multi-year orders from a single customer. Contracts are subject to modification, change or cancellation, and the Company accounts for these changes as they are probable and estimable. The Company evaluates the impact of any scope modifications and will adjust reserves as information is known and estimable.

Successful conversion of engineering program backlog into sales is largely dependent on the execution and completion of our engineering design efforts. It is not uncommon to experience technical or scheduling delays which arise from time to time as a result of, among other reasons, design complexity, the availability of personnel with the requisite expertise, and the requirements to obtain customer approval at various milestones. Cost overruns which may arise from technical and schedule delays could negatively impact the timing of the conversion of backlog into sales, or the profitability of such sales. We continue to experience technical and schedule delays with our major development programs. ~~The issues causing the~~To date, we have been able to resolve various technical and scheduling delays ~~are being resolved as soon as possible.~~and continue to work with our customers on newly arising delays. Engineering programs in both the funded and unfunded portions of the current backlog aggregate $7.2 million.

The growth and continuing demand in the power electronics industry across multiple manufacturing sectors has created volatility and unpredictability in the availability of certain electronic components and, in some cases, continues to create industry shortages. These shortages have and will likely continue to impact our ability to support our customer’s schedule demands, as lead times for these components have, in some instances, increased from readily available to waiting times of nearly a year or more. In addition, we continue to incur delays in material deliveries from some company suppliers due to the COVID-19 pandemic.

Effects from global events and the resulting supply chain disruptions continue to place pressure on the cost of raw materials, freight, utility, labor and other production and administrative costs. These inflationary cost challenges are expected to continue to have a negative impact on operating income in the near term. Volatile raw material indexes and shortages have led to wide-spread vendor price increases. In turn, pricing extended to our customers, through product quotations, has increased, and in some instances significantly, reflective of this unstable inflationary market. In addition, as we navigate through these challenges, we have reduced the time in which certain product quotations remain valid and have also extended lead times, in many instances. As for our executed fixed-priced contracts, we will either singularly or combined be 1) required to absorb the increased costs 2) continue to mitigate costs down through the identification of additional supply chain buying strategies or 3) seek price remediation assistance from our customers. We continue to work with our customers to mitigate any adverse impact upon our ability to service their requirements. ~~These issues, if they persist,~~

Management continues to closely monitor the impact of evolving workforce labor constraints, primarily from the effects from the pandemic, on our planned delivery schedules. Although declining, we continue to experience periodic disruptions from workforce absences due to COVID-19 illnesses and direct contact exposures, resulting in self-isolating protocols to be followed to ensure the safety of company personnel. Disruptions from workforce turnover resulting from a competitive employee market still occurs, however at a decreased rate, having stabilized in the last three months. Several key positions still remain open. Combined, with supply chain constraints, these ongoing labor disruptions may ~~cause us to miss projected delivery dates.~~delay shipments and result in recognizing lower operating income.

Management expects revenues in fiscal year 2022 to be higher than revenues during fiscal year 2021 and expects to generate net income per share as compared to the net loss per share realized during fiscal year 2021. These expectations are driven by orders already in our sales backlog. Creating consistency in our quarter to quarter financial performance will remain a challenge as we move forward navigating this difficult environment of inflation and part shortages.

The Company currently expects new orders in fiscal 2022 to approximate the $38.5 million in new orders received in fiscal year 2021. As market factors including competition and product costs impact gross profit margins, management will continue to evaluate our sales strategy, employment levels, and facility costs.

New orders received in the first ~~six~~nine months of fiscal year 2022 were ~~approximately $19.5~~$34.1 million as compared to ~~$19.4~~$30.8 million new orders received in the first ~~six~~nine months of fiscal 2021. It is presently anticipated that a minimum of ~~$21~~$10 million of orders comprising the ~~December~~March 31, ~~2021~~2022 backlog will be filled during the fiscal year ending June 30, 2022 subject, however, to the impact of the factors identified above. The minimum of ~~$21~~$10 million does not include any shipments, which may be made against orders subsequently received during the fiscal year ending June 30, 2022.

In addition to the backlog, the Company currently has outstanding opportunities representing approximately ~~$63~~$62 million in the aggregate as of ~~February 1,~~May 11, 2022 for both repeat and new programs. The outstanding quotations encompass various new and previously manufactured power supplies, transformers, and subassemblies. However, there can be no assurance that the Company will acquire any of the anticipated orders described above, many of which are subject to allocations of the United States defense spending and factors affecting the defense industry.

A significant portion of the Company’s business is the production of military and industrial electronic equipment for use by the U.S. and foreign governments and certain industrial customers. Net sales to four significant customers represented ~~59%~~approximately 61% of the Company’s total sales for the three-month period ended ~~December~~March 31, ~~2021.~~2022. Net sales to ~~three~~five significant customers represented ~~47%~~66% of the Company’s total sales for the three-month period ended ~~December~~March 31, ~~2020.~~2021. Net sales to ~~five~~four significant customer represented ~~67%~~approximately 55% of the Company’s total sales for the ~~six-month~~nine-month period ended ~~December~~March 31, ~~2021.~~2022. Net sales to four significant customers represented ~~58%~~57% of the Company’s total sales for the ~~six-month~~nine-month period ended ~~December~~March 31, ~~2020. Improvement has been made in customer concentrations recently. However, this high customer concentration level continues to present significant risk.~~2021. A loss of one of these customers or programs related to these customers, or customer requested deferrals of product delivery could significantly impact the Company.

Historically, a small number of customers have accounted for a large percentage of the Company’s total sales in any given fiscal year. Management continues to pursue opportunities with current and new customers with an overall objective of lowering the concentration of sales, mitigating excessive reliance upon a single major product of a particular program and minimizing the impact of the loss of a single significant customer. Given the nature of our business, we believe our existing sales order backlog is fairly diversified in terms of customers and the category of products on order.

Management believes our most critical accounting policies include revenue recognition and cost estimation on our contracts.

The majority of our net sales is generated from contracts with industrial manufacturers and defense companies, the Department of Defense, other agencies of the government of the United States and foreign governments for the design, development and/or manufacture of products. We provide our products and design and development services under fixed-price contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss.

We account for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable. We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time, or were negotiated with an overall profit objective.

We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. Significant judgment is required in determining performance obligations. We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. The transaction price for each performance obligation is based on the estimated standalone selling price of the product or service underlying each performance obligation. Transaction prices on our contracts subject to the Federal Acquisition Regulations (FAR) are typically based on estimated costs plus a reasonable profit margin.

We recognize revenue using the output method based on the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.

Raw materials are valued at the lower of cost (average cost) or net realizable value. Balances for slow-moving and obsolete inventory are reviewed on a regular basis by analyzing estimated demand, inventory on hand, sales levels, market conditions, and other information and reduce inventory balances based on this analysis.

Inventoried work relating to contracts in process and work in process is valued at actual production cost, including factory overhead incurred to date. Contract costs include material, subcontract costs, labor, and an allocation of overhead costs. Work in process represents spare units and parts and other inventory items acquired or produced to service units previously sold or to meet anticipated future orders. Provision for losses on contracts is made when the existence of such losses becomes probable and estimable. The provision for losses on contracts is included in other accrued expenses on the Company’s balance sheet. The costs attributed to units delivered under contracts are based on the estimated average cost of all units expected to be produced. Certain contracts are expected to extend beyond twelve months.

The estimation of total cost at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract. Given the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process. When a change in expected sales value or estimated cost is determined, the change is reflected in current period earnings.

Contract liabilities include advance payments and billings in excess of revenue recognized.

Net sales increased for the three months ended ~~December~~March 31, ~~2021~~2022 to ~~$7,458,050~~$8,620,049 as compared to ~~$6,962,065~~$4,205,068 for the same period in ~~2020.~~2021. Net sales for the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 increased to ~~$15,003,482~~$23,623,531 as compared to ~~$14,227,580~~$18,432,648 for the same period in ~~2020.~~2021. For the three months ended ~~December~~March 31, ~~2021,~~2022, sales increased primarily from an increase in power supply and magnetic ~~sales.~~shipments. For the ~~six~~nine months ended ~~December~~March 31, ~~2021,~~2022, the increase in sales is primarily due to an increase in magnetic, power supply, and build to print ~~and magnetic sales, offset in part, by a decline in power supply, repair and antenna shipments.~~sales. In general, sales fluctuations within product categories will occur during a comparable fiscal period as the direct result of product mix, influenced by the duration of specific programs and the contractual terms of firm orders placed for product and services under those programs including contract value, scope of work and duration. Deliverables within firm contracts are often subject to delivery schedules which also contributes to sales fluctuations between comparable periods. Internal and external constraints, at times, impact our ability to ship.

The impact of ongoing global events, most notably the COVID-19 pandemic, continues to ~~impact raw material delivery schedules with longer lead times on certain raw materials and lends to unplanned~~drive instability in our supply chain. Unplanned employee absences due to sickness and self-isolating protocols ~~in place. In addition, we are experiencing disruptions~~continues, but have been significantly less compared to a year ago. Disruptions from workforce turnover ~~as local businesses emerging~~resulting from a competitive employee market continues, but have begun to subside in the ~~pandemic compete for personnel. These disruptions have a direct impact on~~last three months. However, combined, these ongoing factors continue to constrain our ability to ~~optimally build, test, inspect and~~ ship ~~product.~~ product to our customers.

Specific to the current three and ~~six~~nine month periods discussed above, the sales fluctuations when compared to the same periods last year were primarily the direct result of an unplanned facility closure which occurred in March 2021 due to a significant workforce COVID-19 exposure. The closure lasted approximately 10 days with the facility re-opening at less than full capacity. In addition, the increase in sales in the current fiscal year was influenced by product mix, contractual ~~timing offset, in part,~~due dates, and our ability to deliver on certain past due customer orders which had been delayed due to extended raw material lead times. Finally, sales were favorably impacted by ~~internal and external constraints, all discussed above.~~the completion of certain engineering milestones.

In addition, ~~we continued~~our operations continue to be ~~constrained~~adversely impeded by (i) engineering design changes required to meet customer requirements, (ii) certain supplier product non-conformances, (iii) delays in obtaining timely resolutions on issues encompassing build to print customer-owned drawings, and (iv) an increase in lead times for many parts, including certain electronic components due to industry shortages and volatility within the power electronics industry. Engineering, program management, and supply chain personnel are working closely with our customers and suppliers to execute on our past due deliveries and we do not expect this situation to affect future business opportunities.

Gross ~~profits~~profit (loss) for the three months ended ~~December~~March 31, 2022 and 2021 was $1,734,880 and ~~2020~~$(187,154), respectively. Gross profit (loss) as a percentage of sales was approximately 20.1% and (4.5)%, for the same periods, respectively. For the nine months ended March 31, 2022 and 2021, gross profits were ~~$1,206,817~~$4,294,795 and ~~$713,461,~~$1,653,681, respectively. Gross profit as a percentage of sales was ~~approximately 16.2%~~18.2% and 10.2%, for the same periods, respectively. For the six months ended December 31, 2021 and 2020, gross profits were $2,559,915 and $1,840,835, respectively. Gross profit as a percentage of sales was 17.1% and 12.9%9.0%, for the same periods, respectively. The primary factors in determining the change in gross profit and net income are overall sales levels and product mix. The gross profits on mature products and build to print contracts are typically higher as compared to products which are still in the engineering development stage or in early stages of production. In the case of the latter, the Company can incur what it refers to as “loss contracts,” primarily on engineering design contracts in which the Company invests with the objective of developing future product sales. In any given accounting period the mix of product shipments between higher margin programs and less mature programs, and expenditures associated with loss contracts, has a significant impact on gross profit and net income.

~~Several~~Many factors ~~contributed~~added to an increase in gross profit ~~and the gross profit percentage~~ in the three months ended ~~December~~March 31, ~~2021~~2022 as compared to the same period in ~~2020. First,~~2021. Comparatively, there ~~was an increase~~were several events which occurred in ~~sales on magnetic shipments and~~ the ~~product mix comprising those shipments. This improvement resulted mostly from higher sales and improved margins on a select production contract when compared to sales for the same~~comparable period last ~~year. Second,~~year contributing to the recognized gross loss, which did not have a negative impact on gross profit in the current ~~quarter profit on build to print shipments improved on fairly comparable~~fiscal quarter. First, lower sales ~~in aggregate, between periods,~~ resulting from ~~product mix, and is primarily~~the unplanned facility shutdown due to the COVID-19 pandemic, had a significant impact on gross profit recognized during the three months ended March 31, 2021. Second, also attributable to ~~a specific program in which there were no comparable sales in~~ the ~~prior year. Finally, specific to~~pandemic, the ~~prior year, gross profit was negatively impacted by an~~Company wrote down the remaining value of inventory ~~write-down~~ pertaining to a certain design and production contract serving the airline industry which was cancelled by the ~~customer. These improvements~~customer during the second quarter of the prior fiscal year, and with respect to which the Company was unsuccessful in being awarded restitution. Finally, the Company had recognized increased costs on two specific engineering design and production contracts, which negatively impacted gross profit last year, while accounting for higher sales and contributing to gross profit in the current quarter ~~were offset,~~due to ~~a lesser extent, by~~lower than expected labor costs on certain milestones and production costs required for those contracts. Specific to the expensing of remaining development costs formerly capitalized in inventory on an engineering design program in which our customer has delayed unit qualification testing and for which production units are not expected to be manufactured incurrent fiscal quarter, the ~~near term.~~

~~The improvement in~~Company recognized higher gross profit related to higher sales on mature power supply and ~~the gross profit percentage in the six months ended December 31, 2021 as compared to the same period in 2020 resulted primarily~~ from ~~an increase in sales and the gross profit percentage on magnetic and~~ build to print shipments ~~resulting primarily from product mix. The increase in gross profits on magnetic shipments was primarily driven by the increase in sales on certain mature product~~ when compared to the same period last year. ~~The~~These improvements to gross profit were offset, in part, by an unforeseen significant increase in material costs on a large production contract, a direct result of inflationary and volatile pricing for certain raw materials and components. The Company is reviewing opportunities with the customer concerning potential equitable adjustments to this long-term fixed price contract supporting the US military.

The improvement in gross ~~profits on build to print shipments was primarily driven by~~profit in the ~~increase in sales on certain mature product when~~nine months ended March 31, 2022 as compared to the same period ~~last year, as well as, sales~~in 2021 resulted from an increase in power supply, magnetic and ~~higher margins on a specific program in which there were no comparable sales in the prior year. This improvement in~~ build to print shipments ~~was offset, in part, by increased spending on as specific build~~and product mix comprising those shipments. In addition, similar to ~~print contract~~the three month results discussed above, gross profit for the nine month period improved when compared to the ~~same period last~~prior year as specific items which negatively impacted prior year results did not have a negative impact on gross profit recognized in the current year. ~~Comparatively, and specific~~Reductions to gross profit in the prior year ~~gross profit was negatively impacted by~~included lower sales as the result of an unplanned facility shutdown in the third quarter of last year, and the costs incurred for an inventory write-down ~~pertaining to~~for a ~~certain~~ design and production contract serving the airline industry, which was cancelled by the ~~customer. Gross~~customer during the second quarter of the prior fiscal year. Two specific engineering design and production contracts, which due to increased costs had a negative impact on gross profit last year, had higher sales in the current fiscal year ~~was reduced, in part, by an increase in spending incurred~~and contributed to gross profit. In addition, the Company recognized higher gross profit on ~~several~~increased sales on mature power supply ~~design contracts~~programs and from build to print shipments when compared to the same period last year. ~~In addition,~~These improvements to gross profit were offset, in part, by increased costs incurred on a power supply engineering design and production contract when compared to the prior year. Finally, gross profit was reduced toby a ~~lesser extent, by~~large increase in unforeseen material cost escalations on a large production contract during the ~~expensing~~current quarter of ~~remaining development costs formerly capitalized in inventory on an engineering power supply design contract in which our customer has delayed unit qualification testing~~fiscal 2022, a direct result of the inflationary and volatile pricing for ~~which production units are not expected to be manufactured in the near term.~~certain raw materials and components.

Selling, general and administrative expenses were ~~$1,186,168~~$933,725 for the three months ended ~~December~~March 31, ~~2021, an increase~~2022, a decrease of ~~$240,690,~~$56,586, compared to the three months ended ~~December~~March 31, ~~2020.~~2021. Selling, general and administrative expenses were ~~$2,180,990~~$3,114,715 for the ~~six~~nine months ended ~~December~~March 31, ~~2021,~~2022, an increase of ~~$320,886~~$264,300 compared to the ~~six~~nine months ended ~~December~~March 31, ~~2020.~~2021. The ~~increase~~decrease for the three months ended ~~December~~March 31, ~~2021~~2022 as compared to the same period in ~~2020~~2021 relates primarily to the decrease in employee compensation costs ~~incurred resulting~~due to a reduction in headcount and position vacancies, a decrease in cost associated with scheduled allocated shares from the ~~change~~leveraged ESOP and the decrease in ~~senior management announced at the end~~board of ~~the quarter. The increase for the six months ended December 31, 2021 as compared~~director’s fees due to ~~the same period~~a reduction of two non-employee directors. These decreases were offset, in ~~2020 resulted primarily from the costs recorded in the current quarter as the result of a change in senior management, the~~part, by an increase in costs incurred to recruit and fill company-wide position vacancies, travel, conferences and training, utility expenses and freight costs. The increase for the ~~increase~~nine months ended March 31, 2022 as compared to the same period in 2021 resulted primarily from the costs ~~associated with the stock option grant awarded to employees~~recorded in the ~~first~~second quarter of the current fiscal year as the result of a change in senior management, an increase in costs associated with the current year allocation of shares from the leveraged ESOP transaction dated December 1, 2020 which did not have comparable expense in the six month period last year as the prior leveraged ESOP transaction was fully allocated as of June 30, 2020,incurred to recruit and fill company-wide position vacancies, an increase in professional services due to timing of progress billings, and increase in conferences and training, travel costs, and an increase in ~~travel.~~utility expenses. These increases were offset, in part, by a decrease in ~~direct payroll expense primarily from the department restructuring~~employee compensation costs due to a reduction in headcount and position vacancies and a decrease in board of ~~program management personnel and the timing~~director’s fees due to a reduction of ~~those changes.~~two non-employee directors.

Other income for the three months ended ~~December~~March 31, 2022 and 2021 was $5,661 and ~~2020 was $11,821 and $15,487,~~$7,075, respectively. Other income for the ~~six~~nine months ended ~~December~~March 31, 2022 and 2021 was $37,049 and ~~2020 was $31,388 and $33,831,~~$40,906, respectively. The decrease for the three months ended ~~December~~March 31, ~~2021~~2022 as compared to the same period in ~~2020~~2021 is primarily due to the decrease in other income primarily comprised of income from scrap sales, offset, in part, by an increase in income on the sale of a fixed ~~assets.~~asset. The decrease for the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 as compared to the same period in ~~2020~~2021 is primarily due to a decrease in interest income, resulting from updated investment strategies which yield lower interest while maintaining higher liquidity, offset, in part, by an increase in other income primarily comprised of income from scrap sales. Interest income is a function of the level of investments and investment strategies that generally tend to be conservative.

The Company’s effective tax rate for the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 was approximately ~~34.7%~~18.0% and ~~20.2%~~18.8%, respectively, compared to ~~16.4%~~8.6% and ~~39.5%~~8.2% for the three and ~~six~~nine months ended ~~December~~March 31, ~~2020.~~2021. The effective tax rate in fiscal ~~2021~~2022 and ~~2020~~2021 is less than the statutory tax rate mainly due to the benefit derived from the ESOP dividends paid on allocated shares. The effective tax rate in the three and nine month ~~period~~periods ended ~~December~~March 31, ~~2021~~2022 was higher than the prior year as the direct result of a higher income before taxes in the current fiscal year offset, in part, by a decreased benefit derived from ESOP dividends paid on allocated shares in the current period and from a discreet tax adjustment in the current quarter related to the expiration of non-qualified stock options. The effective tax rate in the six month period ended December 31, 2021 was lower than the prior year as the direct result of decreased benefit derived from ESOP dividends paid on allocated shares in the current period, offset in part, by higher income in the current period when compared to last year.

Net income for the three months ended ~~December~~March 31, ~~2021,~~2022, was ~~$21,201~~$661,359 or ~~$0.01~~$0.27 per share, basic and diluted, compared to net loss of ~~$(181,006)~~$(1,070,114) or ~~$(0.08)~~$(0.44) per share, basic and diluted, for the three months ended ~~December~~March 31, ~~2020.~~2021. Net income for the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 was ~~$327,262~~$988,621 or ~~$0.14~~$0.41 per share, basic and diluted, compared to ~~$8,817~~net loss of $(1,061,297) or ~~$0.00~~$(0.44) per share, basic and diluted, for the ~~six~~nine months ended ~~December~~March 31, ~~2020.~~2021. The increase in net income in the three months ended resulted from the increase in gross profit and ~~six~~the decrease in selling, general and administrative expenses offset, in part, by an increase in the provision for income taxes, all discussed above. The increase in net income in the nine months ended resulted from the increase in gross profit offset, in part, by an increase in selling, general and administrative expenses and an increase in the provision for income taxes, all discussed above.

The Company's working capital is an appropriate indicator of the liquidity of its business, and during the past two fiscal years, the Company, when possible, has funded all of its operations with cash flows resulting from operating activities and when necessary from its existing cash and investments. The Company did not borrow any funds during the last two fiscal years. Management has available a $3,000,000 line of credit to help fund further growth or working capital needs, if necessary, but does not anticipate the need for any borrowed funds in the foreseeable future. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at ~~December~~March 31, ~~2021~~2022 and ~~2020.~~2021. The ~~current~~existing line of credit was extended and expires February 28, ~~2022. It is our expectation the line will be renewed.~~2023.

The Company's working capital as of ~~December~~March 31, ~~2021~~2022 and ~~2020~~2021 was approximately ~~$28.1~~$28.7 million and ~~$27.1~~$26.1 million, respectively. The Company may at times be required to repurchase shares at the ESOP participants’ request at the fair market value. During the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 and ~~2020,~~2021, the Company did not repurchase any shares held by the ESOP. Under existing authorizations from the Company's Board of Directors, as of ~~December~~March 31, ~~2021,~~2022, management is authorized to purchase an additional $783,460 of Company stock.

The table below presents the summary of cash flow information for the fiscal years indicated:

Net cash provided by operating activities fluctuates between periods primarily as a result of differences in sales and net income, provision for income taxes, the timing of the collection of accounts receivable, purchase of inventory, and payment of accounts payable. The decrease in cash provided by operating activities compared to the prior year primarily relates to the decrease in cash collected from trade receivables offset, in part, by an increase in net income and the decrease in inventory purchases. Net cash used in investing activities increased in the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 as compared to the same period in ~~2020~~2021 primarily due to the reinvestment of matured securities when compared to the same period last year. During the ~~six~~nine months ended ~~December~~March 31, ~~2021,~~2022, there was no cash used for financing activities primarily resulting from the suspension of the regular dividend. In the prior year, cash used in financing activities resulted from the payment of regular dividends.

The Company currently believes that the cash flow generated from operations and when necessary, from cash and cash equivalents will be sufficient to meet its long-term funding requirements for the foreseeable future.

During the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 and ~~2020,~~2021, the Company expended ~~$97,288~~$216,500 and ~~$29,173,~~$34,337, respectively, for plant improvements and new equipment. The Company ~~has~~originally budgeted approximately $200,000 for new equipment and plant improvements in fiscal year 2022. Expenditures for new equipment and plant improvements are now expected to approximate $400,000 for the current fiscal year, attributable to the need to accelerate a building roof restoration project, originally expected to occur in a future fiscal year. Management anticipates that the funds required will be available from current operations.

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE

This report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The terms "believe," "anticipate," "intend," "goal," "expect," and similar expressions may identify forward-looking statements. These forward-looking statements represent the Company's current expectations or beliefs concerning future events. The matters covered by these statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including the Company's dependence on timely development, introduction and customer acceptance of new products, the impact of competition and price erosion, supply and manufacturing constraints, potential new orders from customers, the impact of cyber or other security threats or other disruptions to our business, the impact of the COVID-19 pandemic on the United States economy and our operations and other risks and uncertainties. The foregoing list should not be construed as exhaustive, and the Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

The Company is a smaller reporting company as defined under Securities and Exchange Commission Rule 12b-2. Pursuant to the exemption available to smaller reporting company issuers under Item 305 of Regulation S-K, quantitative and qualitative disclosures about market risk, the Company is not required to provide the information for this item.

(a) The Company's management, with the participation of the Company's chief executive officer and chief financial officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

(b) There have been no changes in our internal controls over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

We are party to various litigation matters and claims arising from time to time in the ordinary course of business. While the results of such matters cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows. Currently, there are no matters pending.None

As of ~~December~~March 31, ~~2021~~2022 the Company can repurchase up to $783,460 of its common stock pursuant to an ongoing plan authorized by the Board of Directors. During the quarter ended ~~December~~March 31, ~~2021~~2022 no shares were repurchased.

Effective January 1, 2022, the Company entered an Employment Agreement with Peggy A. Murphy, the Company’s Corporate Secretary, Director of Human Resources and Facility Security Officer, which supersedes the Executive Employment Agreement dated as of March 1, 2013. The Agreement has a term of one year which automatically renews for additional one year periods unless either party gives notice of intention not to renew at least 60 days prior to the end of the current term. Ms. Murphy is entitled to a base salary of $140,400, subject to annual review (but with no decrease) by the Board.None

~~In addition, Ms. Murphy is eligible to receive an annual cash bonus at the discretion of the Board.~~

~~If Ms. Murphy’s employment is terminated without cause, she is entitled to severance pay equal to nine months of her base salary.~~

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

▪		Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.

▪		Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

▪		Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

	December 31, 2021		December 31, 2020		March 31, 2022		March 31, 2021

Dividend yield		0%		5.54%		0%		5.54%
Company’s expected volatility		25.56%		23.41%		25.56%		23.41%
Risk-free interest rate		0.93%		0.36%		0.93%		0.36%
Expected term		5.4 yrs		5.4 yrs		5.4 yrs		5.4 yrs
Weighted average fair value per share of options granted during the period		$3.72		$1.59		$3.72		$1.59

	Employee Stock Options Plan								Employee Stock Options Plan
					Weighted								Weighted
	Number of		Weighted		Average				Number of		Weighted		Average
	Shares		Average		Remaining		Aggregate		Shares		Average		Remaining		Aggregate
	Subject		Exercise		Contractual		Intrinsic		Subject		Exercise		Contractual		Intrinsic
	to Option		Price		Term		Value		to Option		Price		Term		Value
Balance at July 1, 2021		304,662	$	23.37		6.06				304,662	$	23.37		6.06
Granted		77,550	$	14.76		9.56				77,550	$	14.76		9.31
Exercised		0—		0—		—				0—		0—		—
Forfeited or expired		(56,100)	$	20.53		—				(117,234)	$	22.62		—
Outstanding at December 31, 2021		326,112	$	21.81		6.49	$	2,116
Vested or expected to vest at December 31, 2021		307,578	$	22.16		6.32	$	2,029
Exercisable at December 31, 2021		220,287	$	24.58		5.15	$	0
Outstanding at March 31, 2022										264,978	$	21.18		6.57	$	0--
Vested or expected to vest at March 31, 2022										246,809	$	21.56		6.40	$	0--
Exercisable at March 31, 2022										160,953	$	24.51		4.99	$	0--

	Weighted Number		Average	Weighted Number		Average
	of Shares Subject to Option		Grant Date Fair Value (per Option)	of Shares Subject to Option		Grant Date Fair Value (per Option)
Non-vested at July 1, 2021	103,450	$	2.22	103,450	$	2.22
Granted	77,550	$	3.72	77,550	$	3.72
Vested	(43,025)	$	3.03	(43,025)	$	3.03
Forfeited or expired	(32,150)	$	2.58	(33,950)	$	2.55
Non-vested at December 31, 2021	105,825	$	2.89
Non-vested at March 31, 2022				104,025	$	2.90

	December 31, 2021		December 31, 2020		March 31, 2022		March 31, 2021
Allocated shares		478,935		468,663		472,955		467,104
Committed-to-be-released shares		11,568		2,939		17,352		11,755
Unreleased shares		267,861		297,061		262,077		288,245

Total shares held by the ESOP		758,364		768,663		752,384		767,104

Fair value of unreleased shares	$	3,806,305	$	5,620,394	$	3,642,870	$	4,381,324


	Item 2	Management's Discussion and Analysis of Financial Condition and Results of Operations	14

	Item 3	Quantitative and Qualitative Disclosures about Market Risk	20

	Item 4	Controls and Procedures	20

PART II	OTHER INFORMATION		21

	Item 1	Legal Proceedings	21

	Item 2	Unregistered Sales of Equity Securities	21

	Item 3	Defaults Upon Senior Securities	21

	Item 4	Mine Safety Disclosures	21

	Item 5	Other Information	21

	Item 6	Exhibits	21

	SIGNATURES	22

			Gross		Gross						Gross		Gross
	Amortized		Unrealized		Unrealized		Fair		Amortized		Unrealized		Unrealized			Fair
	Cost		Gains		Losses		Value		Cost		Gains		Losses			Value
December 31, 2021
March 31, 2022
Certificates of deposit	$	3,057,000	$	0—	$	0—	$	3,057,000	$	3,139,000	$	0—	$	0—		$	3,139,000
Municipal bonds									$	72,225	$	0—	$	(1,928	)	$	70,297
Total investment securities									$	3,211,225	$	0—	$	(1,928	)	$	3,209,297

June 30, 2021
Certificates of deposit	$	3,092,000	$	0—	$	0—	$	3,092,000	$	3,092,000	$	0—	$	0—		$	3,092,000

	Years to Maturity						Years to Maturity
	Less than		One to				Less than		One to
	One Year		Five Years		Total		One Year		Five Years		Total
December 31, 2021
March 31, 2022
Available-for-sale	$	3,057,000	$	0—	$	3,057,000	$	3,209,297	$	0—	$	3,209,297

June 30, 2021
Available-for-sale	$	3,092,000	$	0—	$	3,092,000	$	3,092,000	$	0—	$	3,092,000

	Six Months Ended December 31,						Nine Months Ended March 31,
	2021			2020			2022			2021
Net cash provided by operating activities	$	277,858		$	2,929,039		$	811,078		$	2,188,300
Net cash (used in) provided by investing activities		(62,288	)		1,910,548			(330,958	)		2,099,830
Net cash used in financing activities		—			(1,201,316	)		—			(1,201,316	)

	~~10.14~~	~~Employment Agreement dated as of January 1, 2022 with Peggy A. Murphy~~

	31.1	Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

	31.2	Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

	32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

	32.2	Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

	ESPEY MFG. & ELECTRONICS CORP.


	/s/ David O’Neil
	David O’Neil
	President and Chief Executive Officer

	/s/Katrina Sparano
	Katrina Sparano
	Principal Financial Officer